ARK/CEO Catherine Wood holds 8.57% of Strata Critical Medical (BLDE)

Rhea-AI Filing Summary

Strata Critical Medical reports that ARK Investment Management LLC and Catherine D. Wood beneficially own 7,455,284 shares of Common Stock, representing 8.57% of the class.

The filing allocates voting and dispositive authority: ARK holds sole voting and sole dispositive power over 7,455,284 shares while Catherine D. Wood holds shared voting and shared dispositive power over 7,455,284 shares. The Schedule 13G/A is signed and dated 04/30/2026.

Insights

Governance & Ownership Specialist

ARK/Wood disclosed an 8.57% beneficial stake with split voting/dispositive authorities.

The filing shows ARK Investment Management LLC as record holder with sole voting and dispositive power for 7,455,284 shares, while Catherine D. Wood is reported with shared voting and dispositive power over the same number. This structure reflects a fund/entity holding with the named individual listed as an affiliated person.

Watch subsequent Schedule 13 filings or amendments that would indicate any change in voting or beneficial ownership; timing and further activity are not specified in the excerpt.

Key Figures

Beneficial ownership: 7,455,284 shares Percent of class: 8.57% Sole voting power (ARK): 7,455,284 shares +2 more

5 metrics

Beneficial ownership 7,455,284 shares Amount beneficially owned as reported in Item 4(a)

Percent of class 8.57% Percent of class reported in Item 4(b)

Sole voting power (ARK) 7,455,284 shares ARK: sole power to vote as reported in Item 4(c)(i)

Shared voting power (C. Wood) 7,455,284 shares Catherine D. Wood: shared power to vote as reported in Item 4(c)(ii)

Filing signature date 04/30/2026 Signed date for the Schedule 13G/A

Key Terms

Beneficially owned, Sole Voting Power, Shared Dispositive Power, Schedule 13G/A

4 terms

Beneficially owned regulatory

"Item 4(a) Amount beneficially owned: ARK and Catherine D. Wood: 7,455,284"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole Voting Power regulatory

"Item 4(c)(i) Sole power to vote or to direct the vote: ARK: 7,455,284"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

Shared Dispositive Power regulatory

"Item 4(c)(iv) Shared Dispositive Power: Catherine D. Wood: 7,455,284"

Schedule 13G/A regulatory

"Form type: SCHEDULE 13G/A (Amendment No. 6)"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/30/2026 - 12:41 PM Learn about SEC filing dates

FAQ

What stake does ARK hold in Strata Critical Medical (BLDE)?

ARK beneficially owns 7,455,284 shares (8.57%). The Schedule 13G/A lists ARK with sole voting and sole dispositive power over those shares and is signed 04/30/2026.

What role does Catherine D. Wood have in the BLDE ownership filing?

Catherine D. Wood is reported with shared voting and shared dispositive power over 7,455,284 shares. She is listed as an affiliated person on the Schedule 13G/A signed 04/30/2026.

Does the filing show any change in BLDE ownership percentages?

The Schedule 13G/A states 8.57% beneficial ownership by ARK and Catherine D. Wood. The excerpt does not include prior-period percentages or a comparative change.

When was the Schedule 13G/A signed for BLDE ownership?

The filing is signed by ARK's compliance officer and Catherine D. Wood on 04/30/2026. The cover lists a date of 03/31/2026 in the header portion of the excerpt.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 6)

Strata Critical Medical, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

092667104

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 092667104

1

Names of Reporting Persons

ARK Investment Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 7,455,284.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 7,455,284.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,455,284.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.57 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP Number(s): 092667104

1

Names of Reporting Persons

Catherine D. Wood

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 7,455,284.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,455,284.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,455,284.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.57 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Strata Critical Medical, Inc.
(b)	Address of issuer's principal executive offices: 31 Hudson Yards, 14th Floor, New York, NY 10001
Item 2.
(a)	Name of person filing: (i) ARK Investment Management LLC ("ARK") (ii) Catherine D. Wood
(b)	Address or principal business office or, if none, residence: ARK and Catherine D. Wood: 200 Central Avenue, St. Petersburg, FL 33701
(c)	Citizenship: (i) ARK: Delaware (ii) Catherine D. Wood: United States
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 092667104
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: ARK and Catherine D. Wood: 7,455,284
(b)	Percent of class: ARK and Catherine D. Wood: 8.57
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: (i) ARK: 7,455,284 (ii) Catherine D. Wood: 0
	(ii) Shared power to vote or to direct the vote: (i) ARK: 0 (ii) Catherine D. Wood: 7,455,284
	(iii) Sole power to dispose or to direct the disposition of: (i) ARK: 7,455,284 (ii) Catherine D. Wood: 0
	(iv) Shared power to dispose or to direct the disposition of: (i) ARK: 0 (ii) Catherine D. Wood: 7,455,284
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

ARK Investment Management LLC

Signature:	/s/ Kellen Carter
Name/Title:	Kellen Carter, Chief Compliance Officer
Date:	04/30/2026

Catherine D. Wood

Signature:	/s/ Catherine D. Wood
Name/Title:	Catherine D. Wood, Chief Executive Officer, Chief Investment Officer
Date:	04/30/2026